Immunome
IPOReinventing Antibody-Drug Conjugates
- Business Model
- B2B
- Website
- immunome.com
- Last Round
- Series BJun 2020
- Rounds
- 11
- Type
- Public
About
Immunome is a clinical-stage oncology company developing first-in-class and best-in-class targeted cancer therapies.
Summary
Immunome is a Biotech company. Its most recent funding was a Series B round in Jun 2020.
Tech & App Stack
2 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2021
Sign up to see all 13 rounds
Seed through IPO — per-round amounts, valuations, and who invested in each round.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/immunome"><img src="https://indexed.vc/api/badge/company/immunome" alt="Immunome on Indexed.vc" width="260" height="76" /></a>